Do you want to read an article? Please log in or register.
The probability of lung cancer in patients with incidentally detected pulmonary nodules: clinical characteristics and accuracy of prediction models
Lung Cancer
RECOMMENDED
Related content
Lung Cancer
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score
Lung Cancer.
Balata H, Foden P, Edwards T, Chaturvedi A, Elshafi M, Tempowski A, Teng B, Whittemore P, Blyth KG, Kidd A, Ellames D, Flint LA, Robson J, Teh E, Jones R, Batchelor T, Crosbie P, Booton R, Evison M
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Fisher A, Kim S, Farhat D, Belzer K, Milczuk M, French C, Mamdani H, Sukari A, Baciewicz F, Schwartz AG, Wozniak A, Nagasaka M
doi: 10.1016/j.cllc.2021.04.004
RECOMMENDED
Lung Cancer
Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models
Thorax.
Raghu VK, Zhao W, Pu J, Leader JK, Wang R, Herman J, Yuan JM, Benos PV, Wilson DO
doi: 10.1136/thoraxjnl-
RECOMMENDED
Lung Cancer
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Borg M, Wen SWC, Nederby L, Hansen TF, Jakobsen A, Andersen RF, Weinreich UM, Hilberg O
doi: 10.1016/j.lungcan.2021.06.010
RECOMMENDED
Lung Cancer
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France
Oncology.
Bigay-Gamé L, Bota S, Greillier L, Monnet I, Madroszyk A, Corre R, Mastroianni B, Falchero L, Mazières J, Colineaux H, Lepage B, Chouaid C; GFPC Investigators
doi: 10.1159/000489784.
RECOMMENDED
Lung Cancer
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug
Lung Cancer.
Stahel RA, Curioni-Fontecedro A, Rohrmann S, Dafni U, Sandner U, Opitz I, Andratschke N, Franzen D, Dimopoulou G, Matthes KL, Kohler M, Guckenberger M, Weder W
doi: 10.1016/j.lungcan.2020.05.037.
RECOMMENDED
Pulmonary Fibrosis
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res.
Holtze CH, Freiheit EA, Limb SL, Stauffer JL, Raimundo K, Pan WT, Flaherty KR, Kim HJ
doi: 10.1186/s12931-020-1315-4.
RECOMMENDED
Lung Cancer
Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Merkhofer CM, Eaton KD, Martins RG, Ramsey SD, Goulart BHL
doi: 10.1016/j.cllc.2021.04.003
Lung Cancer
Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLC
Lung Cancer.
Crane G, Smoljanovic V, Khan N, Gally S, Tomasini P, Lara N, Gondos A, Hammerschmidt S
doi: 10.1016/j.lungcan.